Diagnostic and therapeutic advances have led to much greater awareness of transthyretin cardiac amyloidosis (ATTR-CA). We aimed to characterize changes in the clinical phenotype of patients diagnosed with ATTR-CA over the past 20 years.
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years / Ioannou, A., Patel, R.K., Razvi, Y., Porcari, A., Sinagra, G., Venneri, L., Bandera, F., Masi, A., Williams, G.E., O'Beara, S., Ganesananthan, S., Massa, P., Knight, D., Martinez-Naharro, A., Kotecha, T., Chacko, L., Brown, J., Rauf, M.U., Manisty, C., Moon, J., et al.. - In: CIRCULATION. - ISSN 0009-7322. - ELETTRONICO. - 146:22(2022), pp. 1657-1670. [10.1161/CIRCULATIONAHA.122.060852]
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years
Porcari, Aldostefano;Sinagra, Gianfranco;
2022-01-01
Abstract
Diagnostic and therapeutic advances have led to much greater awareness of transthyretin cardiac amyloidosis (ATTR-CA). We aimed to characterize changes in the clinical phenotype of patients diagnosed with ATTR-CA over the past 20 years.| File | Dimensione | Formato | |
|---|---|---|---|
|
CIRCULATIONAHA.122.060852.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
1.81 MB
Formato
Adobe PDF
|
1.81 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
